J Acquir Immune Defic Syndr
-
Publication Venue For
-
Crowdsourcing Methods to Enhance HIV and Sexual Health Services: A Scoping Review and Qualitative Synthesis..
82 Suppl 3:S271-S278.
2019
-
Hypertension Control and Retention in Care Among HIV-Infected Patients: The Effects of Co-located HIV and Chronic Noncommunicable Disease Care..
82:399-406.
2019
-
Brief Report: Kidney Dysfunction Does Not Contribute Significantly to Antiretroviral Therapy Modification in Treatment-Naive PLWH Receiving Initial ART..
81:e6-e9.
2019
-
Brief Report: Frequency of Monitoring Kidney Function in HIV-Uninfected Persons Using Daily Oral Tenofovir Disoproxil Fumarate Pre-exposure Prophylaxis..
77:206-211.
2018
-
Partnerships Between a University-Affiliated Clinic and Community-Based Organizations to Reach Black Men Who Have Sex With Men for PrEP Care..
77:e25-e27.
2018
-
HIV Preexposure Prophylaxis Implementation at Local Health Departments: A Statewide Assessment of Activities and Barriers..
77:72-77.
2018
-
The Relationship Between Efavirenz as Initial Antiretroviral Therapy and Suicidal Thoughts Among HIV-Infected Adults in Routine Care..
76:402-408.
2017
-
Social Network Clustering and the Spread of HIV/AIDS Among Persons Who Inject Drugs in 2 Cities in the Philippines..
76:26-32.
2017
-
Brief Report: Antibody Responses to Quadrivalent HPV Vaccination in HIV-Infected Young Women as Measured by Total IgG and Competitive Luminex Immunoassay..
75:241-245.
2017
-
PMTCT Option B+ Does Not Increase Preterm Birth Risk and May Prevent Extreme Prematurity: A Retrospective Cohort Study in Malawi..
74:367-374.
2017
-
Illness Perceptions, Medication Beliefs, and Adherence to Antiretrovirals and Medications for Comorbidities in Adults With HIV Infection and Hypertension or Chronic Kidney Disease..
73:403-410.
2016
-
Complications and Route of Delivery in a Large Cohort Study of HIV-1-Infected Women-IMPAACT P1025..
73:74-82.
2016
-
Plasma and Intracellular Concentrations in HIV-Infected Patients Requiring Hemodialysis Dosed With Tenofovir Disoproxil Fumarate and Emtricitabine..
73:e8-e10.
2016
-
Brief Report: Macrophage Activation in HIV-Infected Adolescent Males Contributes to Differential Bone Loss by Sex: Adolescent Trials Network Study 021..
72:372-375.
2016
-
Characteristics of Age-Discordant Partnerships Associated With HIV Risk Among Young South African Women (HPTN 068)..
72:423-429.
2016
-
High-Frequency Illegitimate Strand Transfers of Nascent DNA Fragments During Reverse Transcription Result in Defective Retrovirus Genomes..
72:353-362.
2016
-
Dendritic Cell Immunotherapy for HIV-1 Infection Using Autologous HIV-1 RNA: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial..
72:31-38.
2016
-
Elevations in Serum Creatinine With Tenofovir-Based HIV Pre-Exposure Prophylaxis: A Meta-Analysis of Randomized Placebo-Controlled Trials..
71:e115-e118.
2016
-
Participants' Explanations for Nonadherence in the FEM-PrEP Clinical Trial..
71:452-461.
2016
-
Reversibility of Glomerular Renal Function Decline in HIV-Uninfected Men and Women Discontinuing Emtricitabine-Tenofovir Disoproxil Fumarate Pre-Exposure Prophylaxis..
71:374-380.
2016
-
Effect of Depot Medoxyprogesterone Acetate on Immune Functions and Inflammatory Markers of HIV-Infected Women..
71:137-145.
2016
-
HIV-1 Drug Resistance and Second-Line Treatment in Children Randomized to Switch at Low Versus Higher RNA Thresholds..
70:42-53.
2015
-
Comprehensive Characterization of the Transmitted/Founder env Genes From a Single MSM Cohort in China..
69:403-412.
2015
-
Outcomes Up to 12 Months After Treatment With Loop Electrosurgical Excision Procedure for Cervical Intraepithelial Neoplasia Among HIV-Infected Women..
69:200-205.
2015
-
Immune Reconstitution but Persistent Activation After 48 Weeks of Antiretroviral Therapy in Youth With Pre-Therapy CD4 >350 in ATN 061..
69:52-60.
2015
-
The science of being a study participant: FEM-PrEP participants' explanations for overreporting adherence to the study pills and for the whereabouts of unused pills..
68:578-584.
2015
-
Innate activation of MDC and NK cells in high-risk HIV-1-exposed seronegative IV-drug users who share needles when compared with low-risk nonsharing IV-drug user controls..
68:264-273.
2015
-
Perception of HIV risk and adherence to a daily, investigational pill for HIV prevention in FEM-PrEP..
67:555-563.
2014
-
Changes in proteinuria and albuminuria with initiation of antiretroviral therapy: data from a randomized trial comparing tenofovir disoproxil fumarate/emtricitabine versus abacavir/lamivudine..
67:36-44.
2014
-
HIV and noncommunicable cardiovascular and pulmonary diseases in low- and middle-income countries in the ART era: what we know and best directions for future research..
67 Suppl 1:S40-S53.
2014
-
FEM-PrEP: adherence patterns and factors associated with adherence to a daily oral study product for pre-exposure prophylaxis..
66:324-331.
2014
-
Factors associated with recurrence of cervical intraepithelial neoplasia 2+ after treatment among HIV-infected women in Western Kenya..
66:188-192.
2014
-
World Health Organization's stage 4 conditions among adults accessing outpatient HIV care: a retrospective cohort study in Kisumu, Kenya..
65:e152-e155.
2014
-
Postpartum depression and HIV infection among women in Malawi..
65:359-365.
2014
-
Reduced adherence to antiretroviral therapy among HIV-infected Tanzanians seeking cure from the Loliondo healer..
65:e104-e109.
2014
-
Cost-effectiveness of newer antiretroviral drugs in treatment-experienced patients with multidrug-resistant HIV disease..
64:382-391.
2013
-
Infant growth outcomes after maternal tenofovir disoproxil fumarate use during pregnancy..
64:374-381.
2013
-
Antiretroviral therapy initiated during acute HIV infection fails to prevent persistent T-cell activation..
62:505-508.
2013
-
Associations between HLA-DRB1*0102, HLA-B*5801, and hepatotoxicity during initiation of nevirapine-containing regimens in South Africa..
62:e55-e57.
2013
-
Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals..
61:302-309.
2012
-
Comorbid diabetes and the risk of progressive chronic kidney disease in HIV-infected adults: data from the Veterans Aging Cohort Study..
60:393-399.
2012
-
Role of GB Virus C in Human Immunodeficiency Virus Type-1- and Hepatitis C Virus-infected Hemophiliac Children and Adolescents.
2012
-
Childhood trauma and health outcomes in HIV-infected patients: an exploration of causal pathways..
59:409-416.
2012
-
HIV/HCV-coinfected natural viral suppressors have better virologic responses to PEG-IFN and ribavirin than ARV-treated HIV/HCV patients..
58:e38-e40.
2011
-
Mental health and HIV sexual risk behavior among patrons of alcohol serving venues in Cape Town, South Africa..
57:230-237.
2011
-
Factors associated with decreased kidney function in HIV-infected adults enrolled in the MTCT-Plus Initiative in sub-Saharan Africa..
57:40-45.
2011
-
A cost-effectiveness analysis of alternative HIV retesting strategies in sub-saharan Africa..
56:443-452.
2011
-
Hepatitis B vaccination in HIV-infected youth: a randomized trial of three regimens..
56:325-332.
2011
-
Risk factors influencing antibody responses to Kaposi's sarcoma-associated herpesvirus latent and lytic antigens in patients under antiretroviral therapy..
56:83-90.
2011
-
Acute Dengue fever causes false-positive reactivity in OraQuick rapid HIV-1/2 antibody test..
55:641.
2010
-
HIV risk behavior in treatment-seeking opioid-dependent youth: results from a NIDA clinical trials network multisite study..
55:65-72.
2010
-
Microalbuminuria is associated with all-cause and AIDS mortality in women with HIV infection..
55:73-77.
2010
-
Predicting virologic failure among HIV-1-infected children receiving antiretroviral therapy in Tanzania: a cross-sectional study..
54:368-375.
2010
-
Results of the NIMH collaborative HIV/sexually transmitted disease prevention trial of a community popular opinion leader intervention..
54:204-214.
2010
-
Hepatitis C and the risk of kidney disease and mortality in veterans with HIV..
53:222-226.
2010
-
Characteristics of HIV voluntary counseling and testing clients before and during care and treatment scale-up in Moshi, Tanzania..
52:648-654.
2009
-
Randomized Controlled Trial of an Intervention to Maintain Suppression of HIV Viremia After Prison Release: The imPACT Trial.
2017
-
Improving Depression Among HIV-Infected Adults: Transporting the Effect of a Depression Treatment Intervention to Routine Care.
2016